1. Home
  2. CMTL vs BTAI Comparison

CMTL vs BTAI Comparison

Compare CMTL & BTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comtech Telecommunications Corp.

CMTL

Comtech Telecommunications Corp.

HOLD

Current Price

$3.21

Market Cap

64.4M

Sector

Technology

ML Signal

HOLD

Logo BioXcel Therapeutics Inc.

BTAI

BioXcel Therapeutics Inc.

HOLD

Current Price

$2.10

Market Cap

49.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMTL
BTAI
Founded
1967
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
64.4M
49.2M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
CMTL
BTAI
Price
$3.21
$2.10
Analyst Decision
Strong Buy
Buy
Analyst Count
1
5
Target Price
$6.00
$32.80
AVG Volume (30 Days)
276.9K
658.3K
Earning Date
01-12-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$499,528,000.00
$752,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.15
$544.99
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.19
$1.17
52 Week High
$4.88
$9.26

Technical Indicators

Market Signals
Indicator
CMTL
BTAI
Relative Strength Index (RSI) 58.52 51.76
Support Level $3.00 $1.82
Resistance Level $3.32 $2.33
Average True Range (ATR) 0.20 0.17
MACD 0.01 0.05
Stochastic Oscillator 88.33 62.87

Price Performance

Historical Comparison
CMTL
BTAI

About CMTL Comtech Telecommunications Corp.

Comtech Telecommunications Corp is a provider of modern communications solution incorporated in USA. The company is engaged in designing, developing, producing and marketing products, systems, and services for communications solutions. It is engaged in two business segments, Satellite and Space Communications and Terrestrial and Wireless Networks. It's Space and satellite is USA based providers of modems and high-power amplifiers, a market leader in troposcatter technologies, and serves some of the world's defense contractors and allied foreign governments. Terrestrial and Wireless Networks segment is a provider of next generation 911 infrastructure and solutions for state and local governments and carriers. Majority of sales are generated from Satellite and Space Communications segment.

About BTAI BioXcel Therapeutics Inc.

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.

Share on Social Networks: